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Abstract
Background Lutein is a carotenoid that may play a role in
eye health. Human milk typically contains higher concen-
trations of lutein than infant formula. Preliminary data
suggest there are differences in serum lutein concentrations
between breastfed and formula-fed infants.
Aim of the study To measure the serum lutein concen-
trations among infants fed human milk or formulas with
and without added lutein.
Methods A prospective, double-masked trial was con-
ducted in healthy term formula-fed infants (n = 26) ran-
domized between 9 and 16 days of age to study formulas
containing 20 (unfortiﬁed), 45, 120, and 225 mcg/l of
lutein. A breastfed reference group was studied (n = 14)
and milk samples were collected from their mothers. Pri-
mary outcome was serum lutein concentration at week 12.
Results Geometric mean lutein concentration of human
milk was 21.1 mcg/l (95% CI 14.9–30.0). At week 12, the
human milk group had a sixfold higher geometric mean
serum lutein (69.3 mcg/l; 95% CI 40.3–119) than the
unfortiﬁed formula group (11.3 mcg/l; 95% CI 8.1–15.8).
Mean serum lutein increased from baseline in each formula
group except the unfortiﬁed group. Linear regression
equation indicated breastfed infants had a greater increase
in serum lutein (slope 3.7; P\0.001) per unit increase in
milk lutein than formula-fed infants (slope 0.9; P\0.001).
Conclusions Breastfed infants have higher mean serum
lutein concentrations than infants who consume formula
unfortiﬁed with lutein. These data suggest approximately
4 times more lutein is needed in infant formula than in
human milk to achieve similar serum lutein concentrations
among breastfed and formula fed infants.
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Introduction
Lutein is a carotenoid that selectively accumulates in the
macular region of the retina and protects retinal cells
required for vision [16]. Humans cannot synthesize lutein
and thus all lutein in the human body comes from dietary
sources. Studies in adults have revealed that dietary or
supplemental lutein leads to variable increase both in
serum lutein and in macular pigment [8, 13]. Some epi-
demiological evidence suggests lutein may reduce the risk
of age-related macular degeneration [22, 24].
Lutein may be important well before adulthood. Lutein
is present in cord blood at the time of newborn delivery
indicating placental transfer to the fetus, and cord blood
concentrations are highly correlated to maternal serum
concentrations [28]. Lutein is present in human donor
eyes as early as 17–22 weeks gestation [1, 9]. After birth,
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1 month of age there are differences in serum lutein con-
centrations between breastfed and formula-fed infants [14].
This ﬁnding is plausible because there are higher concen-
trations of lutein in human milk than in infant formulas.
Infant formulas contain a small amount of innate lutein
contributed by ingredients in the formula.
A next step in understanding lutein nutrition in early life
is to determine serum lutein concentrations of exclusively
breastfed and formula-fed infants. The aim of this study
was to examine serum lutein concentrations in infants fed
human milk or formulas unfortiﬁed and fortiﬁed with
lutein. This study is unique because it is the ﬁrst prospec-
tive study of serum lutein concentrations in healthy full-
term infants consuming different concentrations of lutein in
formula in comparison to serum lutein concentrations in
human milk fed infants.
Methods
Subjects
This 3 month double-masked, parallel, prospective
12 week feeding study enrolled exclusively formula-fed
and breastfed infants. Infants were recruited from hospitals
and pediatric practices in the Portland, Oregon area. Ore-
gon Health and Science University Institutional Review
Board approved the study protocol and the informed con-
sent form. Infant inclusion criteria included: healthy sin-
gleton term infants (37–42 weeks gestation) between 9 and
16 days of age, parent or guardian of formula-fed infants
agreed to feed assigned study formula ad libitum, and
breastfeeding mother’s agreed to exclusively breastfeed for
duration of study. An inclusion criterion for a breastfeeding
mother was a self-reported consumption of 6 or more
-cup servings per week of dark green vegetables, which
a r ear i c hs o u r c eo fl u t e i n[ 11]. To verify consumption, each
breastfeeding mother at study entry completed a validated,
semi-quantitative food frequency questionnaire [4]. Ques-
tionnaires were analyzed at the Harvard School of Public
Health and lutein intake was calculated from the Harvard
University food composition database derived from the
USDA Survey Nutrient database plus other sources.
Study formulas
The lutein fortiﬁcation concentrations targeted for this
study were 25, 100, and 200 mcg lutein per liter of for-
mula. These concentrations were chosen because they are
within the range of lutein concentrations observed in the
largest, multinational study of breast milk carotenoids [2].
Study formulas were analyzed several times during the trial
to monitor actual lutein content in the formulas over time.
Lutein was present in the raw material and the innate
amount of lutein was *20 mcg/l, which contributed to the
ﬁnal lutein concentration in the formula. Thus, the four
study formulas contained the following average concen-
trations of lutein as conﬁrmed by analysis: 20 (unfortiﬁed),
45, 120, and 225 mcg/l. At enrollment, formula-fed infants
were randomized to one of these four study formulas, all
of which were based on Wyeth S-26 Gold (Askeaton,
Ireland). The source of lutein for the fortiﬁed formulas was
FloraGLO
 lutein 20% liquid in safﬂower oil (Kemin
Industries, Inc., Des Moines, Iowa). The lutein in this
material was supplied as puriﬁed oleoresin obtained from
the extraction, puriﬁcation, and crystallization of oleoresin
from the marigold ﬂower. A saponiﬁcation step in the
processing created free lutein from lutein esters. Study
formulas were supplied as ready-to-feed liquid in 250 ml
tetrabriks with (per l): 14.3 g protein, 73 g carbohydrate,
36 g fat, and 672 calories. All formulas contained
approximately 135 mcg/l of beta-carotene, and other
micronutrients did not differ among the formulas.
Human milk and serum samples
Human milk was collected using an Avent ISIS
TM breast
pump (Philips Avent, London, UK) [5] at mid-afternoon
from each breastfeeding mother the day before study visit
weeks 4, 8, and 12. A single, mid-afternoon sample of
breast milk represents the average 24-h concentration of
lutein [6]. The mother expressed the sample into clean
bottles and stored it in the home freezer until the study visit
the following day.
Serum lutein concentrations were determined from
infant blood samples collected at baseline and week 12.
Whole blood (1–2 ml) was obtained from each infant by
venipuncture by a registered pediatric phlebotomist or by
heel stick by a pediatric registered nurse.
Human milk and serum samples were stored at -80 Ca t
the study site in a cryobox for light sensitive specimens,
shipped on dry ice to a contract bioanalytical laboratory
(Craft Technologies, Inc., Wilson, North Carolina), and
veriﬁed frozen on arrival. Samples were stored at -70 C
before being analyzed. All laboratory lights were covered
with ultraviolet ﬁlters to protect samples from degradation.
Human milk was analyzed for milk lipid concentration
determinedbycreamatocrit[17]andcarotenoidcomposition.
Lutein and beta-carotene analyses
Serum concentrations of lutein and beta-carotene were
measured by Craft Technologies using high performance
liquid chromatography (HPLC) with multiwavelength
photodiode-array absorbance detection as previously
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an equal volume of buffer and then mixed with two vol-
umes of ethanol containing the internal standard (tocol).
Lutein and beta-carotene were extracted from the aqueous
phase into hexane. The combined hexane extracts were
dried under vacuum. The extract was redissolved in ethyl
acetate and diluted in mobile phase. An aliquot was injected
onto a C18 reversed phase column and eluted isocratically.
The analytes possess absorbance that is proportional to their
concentration in solution and therefore these properties
were used for quantitative analysis. Lutein and beta-caro-
tene were measured by absorbance at 450 nm. Chromato-
grams were recorded using a computer data system.
Analytes were quantiﬁed by external standard quantitation
using neat standards to calculate response factors based on
the peak area of the analyte. The quantities of analytes were
corrected for recovery post-run based on the internal stan-
dard. Coefﬁcient of variation was less than 7%.
Concentrations of these analytes in human milk were
determined after saponiﬁcation of the samples. An aliquot
of milk sample was mixed with potassium hydroxide in
methanol (with pyrogallol added as antioxidant) and
allowed to stand overnight in a refrigerator to hydrolyze
lipids. Each sample was then extracted by use of tetrahy-
drofuran and hexane; the combined extracts of each sample
were evaporated under vacuum and the residue was dis-
solved and analyzed by reversed-phase HPLC as described
above.
Statistical methods
Human milk and serum lutein concentrations were not
normally distributed and data are presented as geometric
means and 95% two-sided conﬁdence intervals. Linear
regression was performed to analyze the relationship
between lutein in the milks and lutein in serum at week 12.
Linear regression analyses were performed with and
without baseline serum lutein concentrations in the model.
Final regression lines do not include baseline serum lutein
concentrations as a covariate.
Results
The mean (SD) age at study entry was 13 (±2.0) days. A
total of 40 infants were enrolled, including 14 human milk-
fed and 26 formula-fed infants (Table 1). Eighty-ﬁve per-
cent (34/40) of enrolled infants completed the study. Six
infants did not complete the study due to the following
reasons: 2 infants were lost to follow-up; 2 families moved
out of the area; 1 infant was no longer exclusively human
milk-fed, and 1 formula-fed infant withdrew due to an
adverse event that was not related to the formula according
to the study pediatrician.
Lutein concentrations in human milk and lutein
in the diet of breastfeeding mothers
Geometric mean lutein concentrations in human milk
samples were similar at weeks 4, 8, and 12 (Table 2). The
mean lipid content of the human milk samples was 41.5 g/l
(95% CI 37.4–46.0). The average lutein concentration from
the three collections of all breastfeeding mothers was
21.1 mcg/l (95% CI 14.9–30.0) and the average amount of
lutein per gram of milk fat was 0.492 mcg (95% CI 0.319–
0.761). Analysis of the Food Frequency Questionnaire,
Table 1 Infant demographic
information at enrollment
Randomized formula-fed group
Formula lutein concentration (mcg/l)
Breastfed group
20 [Control]
(n = 6)
45
(n = 6)
120
(n = 7)
225
(n = 7)
Human milk
(n = 14)
Age at enrollment (days)
Mean ± SD 13 ± 1.3 12 ± 2.7 13 ± 2.1 14 ± 1.1 13 ± 2.1
Median 13 12 14 14 13
Range 11–15 9–15 10–16 12–15 9–15
Female sex [n (%)] 4 (67) 3 (50) 5 (71) 5 (71) 7 (50)
Race [n (%)]
White 5 (83) 5 (83) 6 (86) 4 (57) 12 (86)
Black 1 (17) 0 (0) 0 (0) 0 (0) 0 (0)
Other 0 (0) 1 (17) 1 (14) 3 (43) 2 (14)
Anthropometrics
Weight (kg) 3.8 ± 0.4 3.9 ± 0.6 3.3 ± 0.4 3.9 ± 0.4 3.8 ± 0.4
Length (cm) 51.1 ± 1.5 52.5 ± 3.4 50.1 ± 2.8 51.4 ± 1.1 51.8 ± 2.2
Head circumference (cm) 35.9 ± 1.2 36.1 ± 0.8 34.7 ± 1.2 36.2 ± 1.3 36.1 ± 1.2
Eur J Nutr (2010) 49:45–51 47
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and its structural isomer, zeaxanthin, indicated that the
median lutein plus zeaxanthin in the maternal diet was
3363 mg/day [mean 4286 mg/day (95% CI 2679–5892)].
Lutein concentrations in infant serum
Human milk-fed infants had higher mean serum lutein
concentrations (81 mcg/l) than all formula-fed infants
(13 mcg/l) at baseline. Serum lutein concentration
increased from baseline in each of the formula groups
except in the unfortiﬁed group (Table 3). Linear regression
model with and without baseline serum lutein indicated
baseline serum concentrations did not have a signiﬁcant
effect on ﬁnal serum concentrations in either the formula
(P\0.001) or human milk fed groups (P = 0.001). After
12 weeks of feeding, the human milk group had a sixfold
higher mean serum lutein concentration than the unfortiﬁed
formula group. Fortiﬁcation of formula with lutein resulted
in a dose-dependent increase in serum lutein concentrations
after 12 weeks.
Relationship between dietary lutein and infant serum
lutein concentrations
A positive linear dose-dependent relationship (Fig. 1) was
observed between lutein in the formula and lutein in the
serum. The slope of the regression equation was steeper
for human milk lutein than lutein in formula. For infants
fed human milk, serum lutein concentration increased
approximately 3.7 mcg/l for every 1 mcg/l increase in
human milk lutein concentration, whereas for infants fed
formula, serum lutein concentration increased only
0.9 mcg/l for every 1 mcg/l increase in formula lutein
concentration.
Lutein fortiﬁcation and serum beta-carotene
concentrations
The mean average serum beta-carotene concentration at
baseline across all formula-fed groups was 24.4 mcg/l. In
the infants fed the 20 (control), 45, 120, and 225 mcg/l
lutein containing formulas, the corresponding serum beta-
carotene concentrations at week 12 were 128.0 (95% CI
47.3–346.6), 201.2 (95% CI 98.4–411.2), 173.2 (95% CI
125.5–238.8), and 202.3 mcg/l (95% CI 139.5–293.3),
respectively.
Safety evaluation
Infant growth was within normal limits as assessed by
mean weight gain in grams per day as well as by means for
Z-scores in weight, length, and head circumference (data
not shown). There were no adverse events related to the
formula and no serious adverse events reported.
Table 2 Lutein concentrations in human milk at different study times
Week 4
n = 13
Week 8
n = 13
Week 12
n = 12
Average
n = 13
Lutein (mcg/l)
Geometric mean 20.5 20.1 19.7 21.1
95% CI 12.8–32.9 15.5–26.1 12.3–31.5 14.9–30.0
Median 21 20 21.5 23
Range 6–61 9–37 3–50 7–48
Limit of detection of lutein in human milk was 0.4 mcg/l
Table 3 Lutein concentrations
in infant serum at study entry
and week 12
Limit of detection of lutein in
the serum was 2 mcg/l
Randomized formula-fed group
Formula lutein concentration (mcg/l)
Breastfed group
20 [Control] 45 120 225 Human milk
Study entry
n 66 7 71 4
Geometric mean 11.9 12.9 22.4 8.5 81
95% CI 6–23.9 6.9–24 11.2–45 6.3–11.6 51–128.6
Median 10 13.5 26 8 95
Range 7–40 5–25 8–46 6–17 19–236
Week 12
n 45 7 51 3
Geometric mean 11.3 35.9 107.5 192.1 69.3
95% CI 8.1–15.8 30.1–42.8 88–131.4 141.7–260.6 40.3–119
Median 11.5 37 109 180 66
Range 9–14 31–42 82–148 148–278 7–168
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This is the ﬁrst randomized, prospective study comparing
serum lutein concentrations in healthy term infants con-
suming different concentrations of lutein in formula. An
important ﬁnding from this study is that the breastfed infant
reference group had approximately 6 times the mean serum
lutein concentration of infants consuming unfortiﬁed for-
mula during the ﬁrst several months of life. Fortiﬁcation of
formula with lutein resulted in a dose-dependent increase
in serum lutein. Approximately 4 times more lutein is
needed in the formula than in human milk to achieve
similar serum lutein concentrations among the breastfed
and formula fed infants.
It is interesting to note that despite the similarity in the
lutein concentration of human milk and the unfortiﬁed
formula, serum lutein concentrations were markedly dif-
ferent in the two groups of infants at week 12 but also at
study entry. Two observations may account for this ﬁnding.
Although we did not measure cord blood lutein concentra-
tions, cord blood lutein did not differ at birth among infants
who were ultimately fed human milk or infant formula
(unpublished data, Wyeth, Dr. Minervini, 1993). However,
infants who receive breast milk immediately after birth
most likely consume substantially more lutein from colos-
trum than infants who consume infant formula unfortiﬁed
with lutein [23, 25] and would explain the differences in
serum lutein at study entry. In our study, the mothers
reported at study enrollment that approximately 86% of the
infants in the human milk group were exclusively breastfed
from birth and 77% of the infants in the formula fed group
received exclusively commercial formula.
Secondly, our data suggest that the bioavailability of
lutein from formula is considerably lower than from human
milk and could explain the lower mean serum lutein con-
centration in the unfortiﬁed group at week 12 despite
similar lutein concentrations in the human milk and
unfortiﬁed formula. The ratio of the slopes from the linear
regression lines indicates that a fourfold higher lutein
concentration was needed in formula compared to human
milk to achieve similar lutein concentrations between
formula-fed and breastfed infants. The reason why lutein
availability was different between human milk and lutein-
fortiﬁed formula remains unclear. Lutein added to the
formula is predominantly free lutein and similar to the
dominant form of lutein in human milk. Several ﬁndings
reveal that availability of lutein from foods would be
affected by several factors including the food matrix, fat
intake, and nutrient–nutrient interactions [3, 7, 10, 20, 21,
27]. In relation to those points, additional studies are nee-
ded to explain the difference in bioavailability.
The human milk lutein concentration in this study was
similar to the average values in the largest human milk
survey published to date [2] reporting human milk lutein
data from lactating women in nine countries including the
US. Because dietary carotenoid intake inﬂuences human
milk lutein concentrations, a goal of our study was to enroll
breastfeeding mothers who consumed a diet rich in lutein.
A study inclusion criterion for breastfeeding mothers was a
reported consumption of 6 or more -cup servings per
week of dark green vegetables, which are a rich source of
lutein [11]. The results of the Food Frequency Question-
naire indicated that our goal of recruiting a population of
breastfeeding women with a rich dietary intake of lutein
was achieved. When compared to a sample of women from
the Women’s Health Initiative, the breastfeeding mothers
in our study fell between the 60th and 80th percentiles of
intakes observed in the much larger study (n = 1698) [18].
There is limited information regarding lutein concen-
trations in infant formulas. Lutein is currently not added to
infant formulas in the US but it has been detected in the
ingredients used in infant formula manufacturing. Un-
published data from our laboratory indicate typical skim
milk powder and whey protein ingredients contain lutein
in amounts from \3.3 to 10.2 mcg/100 g and \3.3 to
15.6 mcg/100 g, respectively. One study [12] reported
lutein in formulas and in human milk samples from
Northern Ireland mothers and found that most formulas
studied had detectable lutein and the range of concentra-
tions in formula was similar to the range of concentrations
found in human milk.
Serum beta-carotene concentrations were measured in
this study because interactions between lutein and beta-
carotene have been reported. Competition between lutein
and beta-carotene for absorption was observed in healthy
adults consuming supplements [15] and vegetable sources
[26]. Lutein reduced beta-carotene concentrations in some
Fig. 1 Scatterplot of serum lutein concentrations (mcg/l) at week 12
in infants fed different concentrations (mcg/l) of lutein containing
formula or human milk. Solid circles represent infant formula groups
and open triangles represent human milk group. Linear regression
equation for formula-fed groups was Yi =- 4.4 ? 0.9 (formula
lutein) (r
2 = 0.87, P\0.001) and for the human milk group was
Yi = 1.8 ? 3.7 (human milk lutein) (r
2 = 0.67, P\0.001). Baseline
serum concentrations did not have a signiﬁcant effect on ﬁnal serum
concentrations (P = 0.001 for human milk; P\0.001 for formula)
and the slopes shown are based on unadjusted data
Eur J Nutr (2010) 49:45–51 49
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infants were given formula with the same concentration of
beta-carotene but the infants who consumed lutein sup-
plemented formula had higher mean serum beta-carotene
concentrations than infants who consumed control formula.
These data suggest lutein supplementation enhanced
absorption of beta-carotene but additional studies are nee-
ded to conﬁrm.
The strengths of this study include the use of a wide
range of lutein concentrations in the formula, measurement
of lutein concentrations in the human milk, and the length
of time exclusively formula or breastfed. The small sample
size for each group could be considered a limitation of the
study although a linear dose response relationship was
apparent. The exclusion criteria of infants less than 9 days
old limits our understanding of the amount of lutein in
colostrum and how it might have had an early impact on
baseline serum lutein concentrations. However, requiring
that the infants be older than a week at study entry was
necessary to avoid recruiting into a trial during a time when
a mother might be deciding between breast and formula
feeding.
In summary, infants fed formula unfortiﬁed with lutein
have serum lutein concentrations approximately one-sixth
those of breastfed infants in the ﬁrst few months of life. An
increase in lutein in infant formula leads to an increase in
serum lutein in a dose-dependent manner. More lutein is
needed in infant formula than human milk to achieve
similar serum lutein concentrations among breastfed and
formula fed infants. Additional studies are needed to
demonstrate whether lutein fortiﬁcation in infant formula
leads to improved eye health or other beneﬁts.
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